{"result": "(\"entity\"<|>LOAEL<|>EVENT<|>LOAEL stands for Lowest Observed Adverse Effects Level, which is a critical concept in determining safe nutrient intake levels.)\n##\n(\"entity\"<|>NOAEL<|>EVENT<|>NOAEL stands for No Observed Adverse Effects Level, which is used to establish safe intake levels for nutrients.)\n##\n(\"entity\"<|>UL<|>EVENT<|>UL stands for Tolerable Upper Intake Level, indicating the maximum daily intake of a nutrient that poses no risk of adverse effects.)\n##\n(\"entity\"<|>ARI<|>EVENT<|>ARI stands for Acceptable Risk Intake, which is a guideline for nutrient intake levels.)\n##\n(\"entity\"<|>RDA<|>EVENT<|>RDA stands for Recommended Dietary Allowance, which is the daily dietary intake level sufficient to meet the nutrient requirements of nearly all healthy individuals.)\n##\n(\"entity\"<|>EAR<|>EVENT<|>EAR stands for Estimated Average Requirement, which is the average daily nutrient intake level estimated to meet the requirements of half the healthy individuals in a particular life stage and gender group.)\n##\n(\"relationship\"<|>UNIÓN EUROPEA<|>LOAEL<|>The Unión Europea establishes guidelines that include the concept of LOAEL for determining safe nutrient intake levels.<|>7)\n##\n(\"relationship\"<|>UNIÓN EUROPEA<|>NOAEL<|>The Unión Europea incorporates NOAEL in its guidelines to help define safe intake levels for nutrients.<|>7)\n##\n(\"relationship\"<|>UNIÓN EUROPEA<|>UL<|>The Unión Europea sets UL to ensure that nutrient intake does not exceed levels that could cause adverse effects.<|>8)\n##\n(\"relationship\"<|>UNIÓN EUROPEA<|>ARI<|>The Unión Europea defines ARI to guide acceptable nutrient intake levels for public health.<|>8)\n##\n(\"relationship\"<|>UNIÓN EUROPEA<|>RDA<|>The Unión Europea provides RDA values to help individuals meet their nutritional needs.<|>8)\n##\n(\"relationship\"<|>UNIÓN EUROPEA<|>EAR<|>The Unión Europea uses EAR to estimate the average nutrient requirements for different populations.<|>8)\n<|COMPLETE|>", "input": "MANY entities and relationships were missed in the last extraction. Remember to ONLY emit entities that match any of the previously extracted types. Add them below using the same format:\n", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": [{"role": "user", "content": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: . Para algunos nutrientes (vitamina D, biotina, ac.                               efectos adversos.\npantoténico, sodio, magnesio y manganeso) la Unión                                •  UF (Uncertainty factor) o factor de incertidumbre.\nEuropea establece unos intervalos aceptables de inges-                               Los UF se aplican sobre el LOAEL y preferentemen-\nta (ARI).                                                                            te, si existe, sobre el NOAEL para compensar diver-\n   UL (Tolerable upper intake level) o nivel superior de                             sas incertidumbres: número reducido de indivi-\ningesta Tolerable es el nivel máximo de ingesta cotidia-                             duos analizados, período corto de observación,\nna diaria de un nutriente que no presenta riesgo de                                  variación interindividual, etc. Están comprendidos\npresentar efectos adversos para la mayor parte de la                                 entre 1 y 10. El factor 1 aplicado sobre el NOAEL\npoblación sana a largo plazo. La Unión Europea incluye                               significa que no hay incertidumbre.\notros tres conceptos (figura 1 B).\n                                                                                  En la tabla 1 se recogen, como ejemplo, los valores de\n   •  LOAEL (Lowest observed adverse effects level) o                          las RDA y AI publicados por el IOM para macronutrien-\n      nivel inferior de observación de efectos adversos:                       tes . Las tablas con las DRI para el resto de nutrientes\n\n\n\n                        A.  Definiciones según el Instituto Americano de Medicina\n\n\n\n                           1.0            EAR      RDA                                    UL                           1.0   Risk of Adverse Effects\n\n\n\n                           0.5                                                                                         0.5\n\n\n\n                           0.0                                                                                         0.0\n                                                            Observed Level of Intake\n\n\n\n                        B.  Definiciones según la Unión Europea\n                                                  AR  PRI=RLV                               ULUF 2NOAEL LOAEL\n                                                                                                UF 1\n\n\n\n                                                                     Ingesta óptima\n\n\n\n                                       Ingesta\n                                     Insuficiente                                                          Ingesta excesiva\n                       RIESGO\n                                                                       Ingesta segura\n\n\n\n                                   DÉFICIT                                                                          EFECTOS\n                                                                                                                   ADVERSOS\n                                                                    NIVEL DE INGESTA\n                       El significado de las siglas aparece en el texto.\n                       Modificado de http://www.nap.edu y European Federation Association of Health Products\n                       Manufacturers, EHPM, and European Responsible Nutrition Alliance,ERNA.\n\n\n\n                  Figura 1.    Ingestas dietéticas recomendadas.\n---\n                                                                                           Tema 2.     Requerimientos nutricionales            37\n\n\n\nTabla 1.    Ingestas dietéticas de referencia de macronutrientes.\n\n\n\n        Grupo de edad                Carbohidratos         Fibra total        Lípidos       Ác. linoleico             Ác.            Proteínas\n           población                     (g/día)             (g/día)          (g/día)          (g/día)          α-linolénico          (g/día)\n                                                                                                                   (g/día)\n                  0-6 meses                 60*                 ND              31*              4,4*                0,5*                 9,1*\n  Lactantes       7-12 meses                95*                 ND              30*              4,6*                0,5*               13,5\n                  1-3 años                130                   19*             ND                  7*               0,7*                  13\n  Niños/as        4-8 años                130                   25*             ND                10*                0,9*                  19\n                  9-13 años               130                   31*             ND                12*                1,2*                  34\n                  4-18 años               130                   38*             ND                16*                1,6*                  52\n                  19-30 años              130                   38*             ND                17*                1,6*                  56\n  Hombres         31-50 años              130                   38*             ND                17*                1,6*                  56\n                  51-70 años              130                   30*             ND                14*                1,6*                  56\n                  > 70 años               130                   30*             ND                14*                1,6*                  56\n                  9-13 años               130                   26*             ND                10*                1,0*                  34\n                  14-18 años              130                   26*             ND                11*                1,1*                  46\n                  19-30 años              130                   25*             ND                12*                1,1*                  46\n  Mujeres         31-50 años              130                   25*             ND                12*                1,1*                  46\n                  51-70 años              130                   21*             ND                11*                1,1*                  46\n                  > 70 años               130                   21*             ND                11*                1,1*                  46\n                  14-18 años              175                   28\n######################\nOutput:"}, {"role": "assistant", "content": "(\"entity\"<|>UNIÓN EUROPEA<|>ORGANIZATION<|>The Unión Europea establishes acceptable intake intervals for certain nutrients to ensure public health and safety.)\n##\n(\"entity\"<|>INSTITUTO AMERICANO DE MEDICINA<|>ORGANIZATION<|>The Instituto Americano de Medicina publishes dietary reference intakes and guidelines for various nutrients.)\n##\n(\"entity\"<|>VITAMINA D<|>EVENT<|>Vitamin D is a nutrient that has specific intake recommendations to avoid adverse effects.)\n##\n(\"entity\"<|>BIOTINA<|>EVENT<|>Biotin is a nutrient with established intake levels to prevent negative health impacts.)\n##\n(\"entity\"<|>ÁCIDO PANTOTÉNICO<|>EVENT<|>Pantothenic acid is a nutrient that is included in dietary recommendations to ensure adequate intake.)\n##\n(\"entity\"<|>SODIO<|>EVENT<|>Sodium is a nutrient with specified intake levels to avoid health risks.)\n##\n(\"entity\"<|>MAGNESIO<|>EVENT<|>Magnesium is a nutrient that has recommended intake levels to prevent adverse health effects.)\n##\n(\"entity\"<|>MANGANESO<|>EVENT<|>Manganese is a nutrient with established dietary intake recommendations.)\n##\n(\"relationship\"<|>UNIÓN EUROPEA<|>INSTITUTO AMERICANO DE MEDICINA<|>Both organizations provide guidelines and recommendations for nutrient intake to ensure public health and safety.<|>7)\n##\n(\"relationship\"<|>UNIÓN EUROPEA<|>VITAMINA D<|>The Unión Europea establishes intake levels for Vitamin D to prevent adverse effects.<|>8)\n##\n(\"relationship\"<|>UNIÓN EUROPEA<|>BIOTINA<|>The Unión Europea sets acceptable intake levels for Biotin to avoid negative health impacts.<|>8)\n##\n(\"relationship\"<|>UNIÓN EUROPEA<|>ÁCIDO PANTOTÉNICO<|>The Unión Europea provides dietary recommendations for Pantothenic acid to ensure adequate intake.<|>8)\n##\n(\"relationship\"<|>UNIÓN EUROPEA<|>SODIO<|>The Unión Europea specifies intake levels for Sodium to prevent health risks.<|>8)\n##\n(\"relationship\"<|>UNIÓN EUROPEA<|>MAGNESIO<|>The Unión Europea has established intake recommendations for Magnesium to avoid adverse health effects.<|>8)\n##\n(\"relationship\"<|>UNIÓN EUROPEA<|>MANGANESO<|>The Unión Europea provides dietary intake recommendations for Manganese to ensure public health.<|>8)\n<|COMPLETE|>"}]}